Results 111 to 120 of about 69,664 (311)

Dapagliflozin effect on functional mitral regurgitation and myocardial remodelling: The DEFORM trial

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Functional mitral regurgitation (FMR) is associated with adverse outcomes in patients with heart failure, and current guideline‐directed medical therapy (GDMT) offers limited efficacy in managing FMR. This study aims to evaluate the therapeutic impact of the sodium‐glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in patients with ...
Zhuoshan Huang   +18 more
wiley   +1 more source

Targeted monitoring for human pharmaceuticals in vulnerable source and final waters [PDF]

open access: yes, 2012
A range of pharmaceuticals has been detected in soils, surface waters and groundwaters across the world. While the reported concentrations are generally low (i.e. sub μg l-1 in surface waters), the substances have been observed throughout the year across
Bersuder, Phillipe   +6 more
core  

Contrast-associated acute kidney injury : does it really exist, and if so, what to do about it? [PDF]

open access: yes, 2019
For decades, when contrast agents are administrated, physicians have been concerned because of the risk of inducing acute kidney injury (AKI). Recent literature questions the existence of AKI induced by contrast, but animal studies clearly showed harmful
Hoste, Eric, Vandenberghe, Wim
core   +2 more sources

Pulmonary artery pressure trajectories in heart failure patients treated with GLP‐1 receptor agonists

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Data support favourable haemodynamic benefits of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) on improving cardiac structural abnormalities and function in patients with heart failure (HF). However, the direct haemodynamic effects of GLP‐1 RAs remain inadequately characterized.
Haoran Jiang   +6 more
wiley   +1 more source

Effect of nitroprusside on furosemide-induced skeletal teratogenicity in rat fetuses

open access: yesIranian South Medical Journal, 2016
Background: Furosemide as a loop diuretic can use in treatment of hypertension, renal or heart failures and cirrhosis, when sodium retention is significant.
Mahmood Khaksary Mahabady   +2 more
doaj  

Relationship between antihypertensive medications and cognitive impairment: Part II. Review of Physiology and animal studies [PDF]

open access: yes, 2016
Purpose of Review There is an established association between hypertension and increased risk of poor cognitive performance and dementia including Alzheimer’s disease; however, associations between antihypertensive medications (AHM) and dementia risk are
Carlson, MC   +4 more
core   +1 more source

Acoustic features are independently associated with heart failure and pulmonary hypertension

open access: yesESC Heart Failure, EarlyView.
Abstract Introduction Acoustic analysis of speech has discriminated decompensated acute heart failure (HF). Speech rate (SR) and cepstral peak prominence (CPP) variation are among features previously evaluated. However, the association between SR and CPP and chronic stable HF with and without pulmonary hypertension (PH) as well as PH alone have not ...
Jaskanwal Deep S. Sara   +6 more
wiley   +1 more source

Uji Efektivitas Diuretik Ekstrak Etanol Biji Salak (Salacca Zalacca Varietas Zalacca (Gaert.) Voss) Pada Tikus Putih Jantan Galur Wistar (Rattus Norvegicus) [PDF]

open access: yes, 2014
This research has purpose to examine the diuretic effects of Salak seed\u27s ethanol extract and to analyze the relationship of dose concentration of Salak seed\u27s ethanol extract upon diuretic effect on Wistar white male mice (Rattus norvegicus).
Latuconsina, N. H. (Novita)
core   +3 more sources

Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: A participant‐level pooled analysis of the CANVAS and CREDENCE trials

open access: yesEuropean Journal of Heart Failure, EarlyView.
Among high‐risk patients with T2D, new oral loop diuretic intensification was frequent and portended adverse prognostic significance. Treatment with canagliflozin significantly reduced the need for loop diuretic intensification. ABSTRACT Aims The sodium–glucose cotransporter 2 inhibitor canagliflozin reduces the risk of heart failure (HF ...
Safia Chatur   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy